These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma. Coward P, Lee D, Hull MV, Lehmann JM. Proc Natl Acad Sci U S A; 2001 Jul 17; 98(15):8880-4. PubMed ID: 11447273 [Abstract] [Full Text] [Related]
3. Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Greschik H, Wurtz JM, Sanglier S, Bourguet W, van Dorsselaer A, Moras D, Renaud JP. Mol Cell; 2002 Feb 17; 9(2):303-13. PubMed ID: 11864604 [Abstract] [Full Text] [Related]
4. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor. Pakdel F, Reese JC, Katzenellenbogen BS. Mol Endocrinol; 1993 Nov 17; 7(11):1408-17. PubMed ID: 8114756 [Abstract] [Full Text] [Related]
5. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL. Cell; 1998 Dec 23; 95(7):927-37. PubMed ID: 9875847 [Abstract] [Full Text] [Related]
6. Requirements for transcriptional regulation by the orphan nuclear receptor ERRgamma. Huppunen J, Wohlfahrt G, Aarnisalo P. Mol Cell Endocrinol; 2004 Apr 30; 219(1-2):151-60. PubMed ID: 15149736 [Abstract] [Full Text] [Related]
9. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Feil R, Wagner J, Metzger D, Chambon P. Biochem Biophys Res Commun; 1997 Aug 28; 237(3):752-7. PubMed ID: 9299439 [Abstract] [Full Text] [Related]
10. Development of a coactivator displacement assay for the orphan receptor estrogen-related receptor-gamma using time-resolved fluorescence resonance energy transfer. Gowda K, Marks BD, Zielinski TK, Ozers MS. Anal Biochem; 2006 Oct 01; 357(1):105-15. PubMed ID: 16889744 [Abstract] [Full Text] [Related]
12. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. Doesburg P, Kuil CW, Berrevoets CA, Steketee K, Faber PW, Mulder E, Brinkmann AO, Trapman J. Biochemistry; 1997 Feb 04; 36(5):1052-64. PubMed ID: 9033395 [Abstract] [Full Text] [Related]
19. FLP recombinase/estrogen receptor fusion proteins require the receptor D domain for responsiveness to antagonists, but not agonists. Nichols M, Rientjes JM, Logie C, Stewart AF. Mol Endocrinol; 1997 Jun 16; 11(7):950-61. PubMed ID: 9178754 [Abstract] [Full Text] [Related]